Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis (MS-BMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01811290
Recruitment Status : Unknown
Verified January 2018 by Virginia I. Simnad, MD, Simnad, Virginia, M.D..
Recruitment status was:  Active, not recruiting
First Posted : March 14, 2013
Last Update Posted : February 1, 2018
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Virginia I. Simnad, MD, Simnad, Virginia, M.D.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : December 2018